In the placebo group, only waist circumference, and not body weight, showed a similar association
It says formulations are typically supplied between 2.5 mg/mL and 5 mg/mL, and argues that this range allows flexibility in strength without changing the volume being injected
We cannot treat this as if it's total, like we've never seen anything like this before, when we know that appetite suppressants have had over 100 years to prove that they work, and there have been various iterations
Glucagon-receptor agonism is thought to raise energy expenditure and mobilize liver fat, adding an energy burn component on top of appetite suppression
Conversely, keeping them restricted forces pharmacies to enforce strict quality audits and avoid these active pharmaceutical ingredients (APIs) entirely